Arash Aghajani Nargesi

Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020

Lovedeep Singh Dhingra, Arya Aminorroaya, Evangelos K. Oikonomou et al. · JAMA Network Open · 2023 · 126 citations · Full text

Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images

Veer Sangha, Arash Aghajani Nargesi, Lovedeep Singh Dhingra et al. · Circulation · 2023 · 113 citations · Full text

Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair

Arash Aghajani Nargesi, Lilach O. Lerman, Alfonso Eirin · Current Gene Therapy · 2017 · 106 citations · Full text

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus

Arash Aghajani Nargesi, Gini Priyadharshini Jeyashanmugaraja, Nihar R. Desai et al. · Journal of the American Heart Association · 2021 · 63 citations · Full text

Heart Failure, Metabolic Syndrome, Diabetes Epidemiology +16

Assessment of serum 25-hydroxy vitamin D improves coronary heart disease risk stratification in patients with type 2 diabetes

Behnam Heidari, Arash Aghajani Nargesi, Nima Hafezi‐Nejad et al. · American Heart Journal · 2015 · 52 citations

Metabolic Syndrome, Cardiovascular Disease, Global Health +7